权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Immunotherapeutic Regulatory CD8 T cells in Autoimmune Demyelinating Disease

自身免疫性脱髓鞘疾病中的免疫治疗调节性 CD8 T 细胞

基本信息

批准号：
9338988
负责人：
NITIN J KARANDIKAR
金额：
--
依托单位：
IOWA CITY VA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-07-01 至 2021-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9338988
关键词：
Address Adoptive Immunotherapy Adoptive Transfer Affect Animal Model Anti-Inflammatory Agents Anti-inflammatory Antigenic Specificity Antigens Area Autoantigens Autoimmune Diseases Autoimmune Process CD4 Positive T Lymphocytes CD8-Positive T-Lymphocytes CD8B1 gene Cells Characteristics Chronic Country Data Demyelinating Diseases Demyelinations Dendritic Cells Development Disease Exhibits Experimental Autoimmune Encephalomyelitis Experimental Models Goals Histology Human ITGAX gene Immune Immunization Immunologics Immunology Immunotherapeutic agent Immunotherapy In Vitro Inbred C3H Mice Inflammatory Interferon Type II Intervention Intuition MHC Class I Genes Mediating Modeling Molecular Morbidity - disease rate Multiple Sclerosis Multiple Sclerosis Lesions Mus Myelin Neuraxis Organ Pathogenesis Pathogenicity Pathology Pathology processes Peripheral Pharmaceutical Preparations Phenotype Play Population Process Regulation Regulatory T-Lymphocyte Relapse Reporting Role SJL Mouse Site T-Lymphocyte Therapeutic Therapeutic Effect Transgenic Organisms Veterans Work arm autoreactive T cell autoreactivity base central nervous system demyelinating disorder copolymer 1 cytotoxic experimental study immunopathology immunoregulation in vivo innovation insight mouse model neuroinflammation novel perforin response trafficking treatment strategy

项目摘要

Multiple sclerosis (MS) is an inflammatory, demyelinating disorder of the central nervous system (CNS). A great deal of our understanding about the immunologic processes that underlie MS derives from studies in its autoimmune animal model, experimental autoimmune encephalomyelitis (EAE). However, the vast majority of studies in EAE and MS have focused on evaluating and targeting CD4+ T cell responses, with the general assumption that these diseases are predominantly Th1/Th17-mediated and Th2/Treg-modulated. Recent reports from others and us indicate that CD8+ T cells play a role in the pathogenesis as well as regulation of autoimmune demyelination. Our recent studies in MS and EAE have provided evidence for a novel and unexpected disease suppressive role for CNS-specific CD8+ T cells and also demonstrated the requirement of CD8+ T cells in mediating effects of glatiramer acetate (GA) immunotherapy. Based on our data, we hypothesize that a subset of autoantigen-specific or GA-induced CD8 T cells form an important arm of immune regulation during autoimmune demyelinating disease. We propose that this process can be harnessed for the development of an effective immunotherapeutic strategy. The experiments proposed in this application will utilize EAE models to address the fundamental cellular and molecular mechanisms of immune modulation by intrinsic and therapeutic CD8 T cells. In addition, the most potent immune suppressive subset of these populations will be defined with the goal of developing a novel adoptive immunotherapeutic approach. We believe that the proposed experiments will provide greater fundamental insights into CD8 T cell-mediated immune regulation and pave the way for newer intervention strategies for this and other immune-mediated diseases.

多发性硬化症（MS）是一种中枢神经系统（CNS）的炎症性脱髓鞘疾病。一个